SEC No-Action Letter: H&Q Life Sciences Investors
SEC No-Action Letter re. Omission of Shareholder Proposal Pursuant to Rule 14a-8 for H&Q Life Sciences Investors
March 24, 2011
The SEC Division of Investment Management granted no-action relief to an fund to omit a shareholder proposal from its proxy statement for its 2011 annual meeting. The Division found that the proposal was "substantially duplicative" of a previously submitted proposal that was included in the fund's proxy materials, and thus could be omitted under Exchange Act Rule 14a-8(i)(11).
Cross References
Exchange Act Rule 14a-8(i)(11)